Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
  1. 4 Planned sale EVP, CFO & CBO sold 124,042 shares at an average $90.52 ($11,228,720)
  2. 4 Planned sale CHIEF ACCOUNTING OFFICER sold 20,000 shares at an average $101.38 ($2,027,646)
  3. 4 Planned sale EVP, Head of R&D sold 23,124 shares at an average $106.41 ($2,460,690)
  4. 4 Planned sale Director sold 2,778 shares at $117.55 ($326,554)
  5. 4 Option exercise SVP, General Counsel and Sec. acquired 15,000 shares (option exercise)
  6. 4 Planned sale Director sold 7,750 shares at an average $109.01 ($844,822)
  7. 4 Planned sale Director sold 2,777 shares at an average $109.55 ($304,232)
  8. 4 Planned sale SVP, General Counsel and Sec. sold 20,000 shares at an average $110.44 ($2,208,833)
  9. 4 Planned sale CEO AND PRESIDENT sold 166,000 shares at an average $108.11 ($17,945,451)
  10. 4 Planned sale EVP, CFO & CBO sold 31,249 shares at an average $101.03 ($3,157,151)
  11. 4 Planned sale SVP, General Counsel and Sec. sold 30,000 shares at an average $80.80 ($2,423,958)
  12. 4 Planned sale EVP, Head of R&D sold 26,530 shares at an average $90.62 ($2,404,077)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Planned sale Director sold 599 shares at $85.47 ($51,197)

Page 1 of 15 · 290 filings